Literature DB >> 28747508

Mutations in the E2 Glycoprotein and the 3' Untranslated Region Enhance Chikungunya Virus Virulence in Mice.

David W Hawman1, Kathryn S Carpentier1, Julie M Fox2, Nicholas A May1, Wes Sanders3, Stephanie A Montgomery4, Nathaniel J Moorman3, Michael S Diamond2,5,6,7, Thomas E Morrison8.   

Abstract

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes debilitating musculoskeletal pain and inflammation and can persist for months to years after acute infection. Although studies of humans and experimentally infected animals suggest that CHIKV infection persists in musculoskeletal tissues, the mechanisms for this remain poorly understood. To evaluate this further, we isolated CHIKV from the serum of persistently infected Rag1 -/- mice at day 28. When inoculated into naive wild-type (WT) mice, this persistently circulating CHIKV strain displayed a capacity for earlier dissemination and greater pathogenicity than the parental virus. Sequence analysis revealed a nonsynonymous mutation in the E2 glycoprotein (E2 K200R) and a deletion within the 3' untranslated region (3'-UTR). The introduction of these changes into the parental virus conferred enhanced virulence in mice, although primary tropism for musculoskeletal tissues was maintained. The E2 K200R mutation was largely responsible for enhanced viral dissemination and pathogenicity, although these effects were augmented by the 3'-UTR deletion. Finally, studies with Irf3/Irf7 -/- and Ifnar1 -/- mice suggest that the E2 K200R mutation enhances viral dissemination from the site of inoculation independently of interferon regulatory factor 3 (IRF3)-, IRF7-, and IFNAR1-mediated responses. As our findings reveal viral determinants of CHIKV dissemination and pathogenicity, their further study should help to elucidate host-virus interactions that determine acute and chronic CHIKV infection.IMPORTANCE CHIKV is a globally spreading, mosquito-transmitted virus that causes debilitating acute and chronic musculoskeletal disease in humans. The viral genetic determinants that dictate the severity of acute and chronic diseases are not understood. To improve our understanding of CHIKV pathogenesis, we evaluated a CHIKV strain isolated from the serum of chronically infected immunocompromised mice. Sequence analysis of this persistent CHIKV strain identified two mutations, an amino acid change in the E2 viral attachment protein and a deletion within the 3'-UTR of the viral genome. We identified roles for these mutations in the enhancement of viral dissemination from the inoculation site and in disease severity. These data improve our understanding of the viral determinants of CHIKV pathogenesis and adaptive changes that occur during viral persistence.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  alphavirus; chikungunya virus; viral pathogenesis; virulence determinants

Year:  2017        PMID: 28747508      PMCID: PMC5625495          DOI: 10.1128/JVI.00816-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

Review 1.  Chikungunya: Evolutionary history and recent epidemic spread.

Authors:  Scott C Weaver; Naomi L Forrester
Journal:  Antiviral Res       Date:  2015-05-12       Impact factor: 5.970

2.  Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Authors:  Clémentine Schilte; Thérèse Couderc; Fabrice Chretien; Marion Sourisseau; Nicolas Gangneux; Florence Guivel-Benhassine; Anton Kraxner; Jürg Tschopp; Stephen Higgs; Alain Michault; Fernando Arenzana-Seisdedos; Marco Colonna; Lucie Peduto; Olivier Schwartz; Marc Lecuit; Matthew L Albert
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

3.  The 3' untranslated region of sindbis virus represses deadenylation of viral transcripts in mosquito and Mammalian cells.

Authors:  Nicole L Garneau; Kevin J Sokoloski; Mateusz Opyrchal; C Preston Neff; Carol J Wilusz; Jeffrey Wilusz
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

4.  Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.

Authors:  David W Hawman; Kristina A Stoermer; Stephanie A Montgomery; Pankaj Pal; Lauren Oko; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

5.  Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence.

Authors:  Konstantin A Tsetsarkin; Scott C Weaver
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

6.  Novel chikungunya virus variant in travelers returning from Indian Ocean islands.

Authors:  Philippe Parola; Xavier de Lamballerie; Jacques Jourdan; Clarisse Rovery; Véronique Vaillant; Philippe Minodier; Philippe Brouqui; Antoine Flahault; Didier Raoult; Rémi N Charrel
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

7.  RNA viruses can hijack vertebrate microRNAs to suppress innate immunity.

Authors:  Derek W Trobaugh; Christina L Gardner; Chengqun Sun; Andrew D Haddow; Eryu Wang; Elik Chapnik; Alexander Mildner; Scott C Weaver; Kate D Ryman; William B Klimstra
Journal:  Nature       Date:  2013-12-18       Impact factor: 49.962

8.  The structural basis of pathogenic subgenomic flavivirus RNA (sfRNA) production.

Authors:  Erich G Chapman; David A Costantino; Jennifer L Rabe; Stephanie L Moon; Jeffrey Wilusz; Jay C Nix; Jeffrey S Kieft
Journal:  Science       Date:  2014-04-18       Impact factor: 47.728

9.  Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period.

Authors:  Daouda Sissoko; Denis Malvy; Khaled Ezzedine; Philippe Renault; Frederic Moscetti; Martine Ledrans; Vincent Pierre
Journal:  PLoS Negl Trop Dis       Date:  2009-03-10

10.  Human muscle satellite cells as targets of Chikungunya virus infection.

Authors:  Simona Ozden; Michel Huerre; Jean-Pierre Riviere; Lark L Coffey; Philippe V Afonso; Vincent Mouly; Jean de Monredon; Jean-Christophe Roger; Mohamed El Amrani; Jean-Luc Yvin; Marie-Christine Jaffar; Marie-Pascale Frenkiel; Marion Sourisseau; Olivier Schwartz; Gillian Butler-Browne; Philippe Desprès; Antoine Gessain; Pierre-Emmanuel Ceccaldi
Journal:  PLoS One       Date:  2007-06-13       Impact factor: 3.240

View more
  13 in total

1.  Lack of nsP2-specific nuclear functions attenuates chikungunya virus replication both in vitro and in vivo.

Authors:  Chetan D Meshram; Tetyana Lukash; Aaron T Phillips; Ivan Akhrymuk; Elena I Frolova; Ilya Frolov
Journal:  Virology       Date:  2019-05-28       Impact factor: 3.616

2.  MARCO+ lymphatic endothelial cells sequester arthritogenic alphaviruses to limit viremia and viral dissemination.

Authors:  Kathryn S Carpentier; Ryan M Sheridan; Cormac J Lucas; Bennett J Davenport; Frances S Li; Erin D Lucas; Mary K McCarthy; Glennys V Reynoso; Nicholas A May; Beth A J Tamburini; Jay R Hesselberth; Heather D Hickman; Thomas E Morrison
Journal:  EMBO J       Date:  2021-10-07       Impact factor: 14.012

3.  Two Conserved Phenylalanine Residues in the E1 Fusion Loop of Alphaviruses Are Essential for Viral Infectivity.

Authors:  Cormac J Lucas; Bennett J Davenport; Kathryn S Carpentier; Alex N Tinega; Thomas E Morrison
Journal:  J Virol       Date:  2022-04-13       Impact factor: 6.549

4.  Chikungunya Outbreaks in India: A Prospective Study Comparing Neutralization and Sequelae during Two Outbreaks in 2010 and 2016.

Authors:  Jaspreet Jain; Navjot Kaur; Sherry L Haller; Ankit Kumar; Shannan L Rossi; Vimal Narayanan; Dilip Kumar; Rajni Gaind; Scott C Weaver; Albert J Auguste; Sujatha Sunil
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

5.  Chikungunya virus replication in skeletal muscle cells is required for disease development.

Authors:  Anthony J Lentscher; Mary K McCarthy; Nicholas A May; Bennett J Davenport; Stephanie A Montgomery; Krishnan Raghunathan; Nicole McAllister; Laurie A Silva; Thomas E Morrison; Terence S Dermody
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

6.  Construction and characterization of a full-length infectious clone of Getah virus in vivo.

Authors:  Tongwei Ren; Xiangling Min; Qingrong Mo; Yuxu Wang; Hao Wang; Ying Chen; Kang Ouyang; Weijian Huang; Zuzhang Wei
Journal:  Virol Sin       Date:  2022-03-11       Impact factor: 6.947

Review 7.  Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream.

Authors:  Stephanie E Ander; Frances S Li; Kathryn S Carpentier; Thomas E Morrison
Journal:  PLoS Pathog       Date:  2022-05-05       Impact factor: 7.464

8.  Genetic characterization of Chikungunya virus 2009 isolates from South India.

Authors:  Gopalsamy Sarangan; Seema A Nayar; Monika Mani; Sudharsana Sundarrajan; Sathish Sankar; Gunasekaran Palani; Gracy Fathima Selvaraj; Jayachandran Damodharan; Karuppaiah Muthumani; Padma Srikanth
Journal:  Bioinformation       Date:  2018-03-31

9.  Identification of Quinolinones as Antivirals against Venezuelan Equine Encephalitis Virus.

Authors:  Nicole N Haese; Nicholas A May; Sharon Taft-Benz; Omar Moukha-Chafiq; Nikhil Madadi; Sixue Zhang; Shuklendu D Karyakarte; Kevin J Rodzinak; Theresa H Nguyen; Michael Denton; Aaron D Streblow; Nichole A Towers; Lynn Rasmussen; Robert J Bostwick; Joseph A Maddry; Subramaniam Ananthan; Corinne E Augelli-Szafran; Mark J Suto; Wes Sanders; Nathaniel Moorman; Victor DeFilippis; Mark T Heise; Ashish K Pathak; Daniel N Streblow; Thomas E Morrison
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

Review 10.  De-Coding the Contributions of the Viral RNAs to Alphaviral Pathogenesis.

Authors:  Autumn T LaPointe; Kevin J Sokoloski
Journal:  Pathogens       Date:  2021-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.